8F-Fluoro-1-Naphthol

N/A

Report date: 2026/01/12 20:00:53
NME

Base Information

Drug Name8F-Fluoro-1-Naphthol
Drug Alias Name4-[18F]Fluoro-1-Naphthol18F-4FN[18F]4FN
ClassificationDiagnostic agent (In vivo) > Radionuclide Imaging agentRadiation-emitting products > Nuclides > Fluorine > 18FSmall molecules +[5] 
Mechanisms of ActionPositron-emission tomography enhancersMyeloperoxidase binders
TargetsMyeloperoxidase
Therapy Area/IndicationsContrast agentsGraft vs Host DiseaseEndocrine Gland Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesThe University Of Texas MD Anderson Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesThe University Of Texas MD Anderson Cancer Center
Inactive CompaniesN/A
Active IndicationsContrast agentsGraft vs Host DiseaseEndocrine Gland Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A